Testing effectiveness (Phase 2)Study completedNCT00358930
What this trial is testing
ARQ 501 in Patients With Squamous Cell Carcinoma of the Head and Neck
Who this might be right for
Head and Neck NeoplasmsCarcinoma, Squamous Cell
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) 60